Medical oncologist with more than three decades of clinical experience spanning academic oncology in the United States and independent oncology practice in Istanbul. Founder of Tansan Oncology, established in 1995. Clinical interests focus on precision oncology, molecularly informed treatment selection, targeted therapy, immunotherapy, and the management of complex and advanced cancers. Particular emphasis is placed on reassessing tumor biology over the course of disease and integrating clinically meaningful molecular findings into treatment decisions.

Education and Expertise
1983 Medical Doctor, Istanbul University Faculty of Medicine, Istanbul
1986–1989 Internal Medicine Residency Training, Carney Hospital, Boston, Massachusetts, USA
1989–1991 Medical Oncology Advanced Training, Boston University Medical Center, Boston, Massachusetts, USA

Board Certification
1991 American Board – Medical Oncology certification

Academic and Clinical Responsibilities

1991 Assistant Professor of Medicine (Tenure Track), Boston University

1991–1995 Director of Chemotherapy Clinic, Boston University; postgraduate medical education and clinical oncology roles.

1995–Present Founder and Medical Oncology Specialist, Tansan Oncology, Istanbul

Awards and Achievements

• Distinguished Physician Award, Boston University School of Medicine / affiliated hospital, 1991–1995
• 98th percentile on the American Board of Internal Medicine exam.

Current Clinical Focus Areas

•  Precision oncology and personalized systemic treatment strategies.
•  Molecular and genomic profiling in solid tumors
•  Interpretation of therapeutically significant biomarkers and resistance mechanisms.
•  Targeted therapies and immunotherapy
•  Complex and advanced-stage cancers after multiple treatments
•  In disease progression, re-evaluation with tissue profiling and fluid biopsy should be performed when appropriate.
•  Evaluating new treatment approaches alongside established treatment standards.

Professional Competencies

• Medical oncology
• • Systemic anticancer therapy
• Precision oncology
• Molecular tumor profiling
• Targeted therapies
• Cancer immunotherapy
• Clinical interpretation of liquid biopsy
• Advanced cancer treatment strategy